Alex Kotzer
Keine laufenden Positionen mehr
Karriereverlauf von Alex Kotzer
Ehemalige bekannte Positionen von Alex Kotzer
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Regenera Pharma Ltd.
 Regenera Pharma Ltd. Pharmaceuticals: MajorHealth Technology Regenera Pharma Ltd. develops a novel drug candidate, RPH201 for neurological indications. It also focuses on developing a treatment for Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), the most common cause of sudden optic nerve-related vison loss in older people. The company is headquartered in Ness-Ziona, Israel. | Vorstandsvorsitzender | 25.03.2010 | - |
| Vorsitzender | 25.03.2010 | - | |
| COMPUGEN LTD. | Direktor/Vorstandsmitglied | 03.06.2009 | - |
| Präsident | 01.09.2005 | 03.06.2009 |
Ausbildung von Alex Kotzer
| Technion-Israel Institute of Technology | Undergraduate Degree |
Statistik
International
| Israel | 4 |
Operativ
| Director/Board Member | 1 |
| President | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| COMPUGEN LTD. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Regenera Pharma Ltd.
Regenera Pharma Ltd. Pharmaceuticals: MajorHealth Technology Regenera Pharma Ltd. develops a novel drug candidate, RPH201 for neurological indications. It also focuses on developing a treatment for Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), the most common cause of sudden optic nerve-related vison loss in older people. The company is headquartered in Ness-Ziona, Israel. | Health Technology |
- Börse
- Insiders
- Alex Kotzer
- Erfahrung
